3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasm, Residual
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Locally Advanced Rectal Carcinoma
1
Gliosarcoma
1
Glioma
1
Genetic Diseases, Inborn
1
Esophageal Neoplasms
1
Circulating Tumor DNA
1
Carcinoma, Non-Small-Cell Lung
1
Astrocytoma
1
Interventions
Melphalan
3
Blood Specimen Collection
3
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
sargramostim
1
romidepsin
1
montanide ISA 51
1
keyhole-limpet hemocyanin
1
ixazomib
1
detox adjuvant
1
Waiting Lists
1
Ursodeoxycholic Acid
1
Transplantation
1
Thalidomide
1
Tablets
1
Streptozocin
1
Radiosurgery
1
Radiation
1
Mercaptopurine
1
Leucovorin
1
Ketoconazole
1
Interleukin-2
1
Fulvestrant
1
Floxuridine
1
FANG vaccine
1
Docetaxel
1
Cord Blood Stem Cell Transplantation
1
Clinical Trials, Phase II as Topic
1
Circulating Tumor DNA
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genetic Diseases, Inborn
×
Circulating Tumor DNA
×
Clear all
NCT03115138
2020-07-15
Bi-GLAM
Centre Hospitalier Universitaire, Amiens
Phase NA
Terminated
19 enrolled